Projects per year
Personal profile
Research Interests
Pharmaceutical Chemistry
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Phd الكيمياء الصيدلية-جامعة هامدارد
Fingerprint
Dive into the research topics where Mehnaz Kamal Uddin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
2022/03/20826: Synthesis, characterization, in silico screening and biological evaluation of some novel sulfonamide conjugates as antibacterial agents
Fayaz Shaik, A. (PI) & Kamal Uddin, M. (PI)
23/03/22 → 23/03/23
Project: Research
-
2022/02/20833: Intelligent classification of fake social media audio news in digital age and its impact on modern society using deep learning
Kamal Uddin, M. (PI) & Ali Bahaj, S. (PI)
23/03/22 → 23/03/23
Project: Research
-
Chroman-Schiff base derivatives as potential Anti-Tubercular Agents: In silico studies, Synthesis, and Biological evaluation
Mujeeb, S., Singh, K., Al-Zrkani, M. K., Al-Fahad, D., Hasan, S. M., Shouber, M. A., Ahmad, F., Hameed, H. N., Iqbal, D. & Kamal, M., Apr 2025, In: Bioorganic Chemistry. 157, 108249.Research output: Contribution to journal › Article › peer-review
-
Computational mechanistic insight of fungal metabolites for novel acetylcholinesterase inhibitors
Alyenbaawi, H., Alsaweed, M., Jamal, Q. M. S., Asad, M. R., Rizvi, S. M. D., Ahmad, F., Kamal, M. & Iqbal, D., 2025, (Accepted/In press) In: Molecular Diversity.Research output: Contribution to journal › Article › peer-review
-
Design, Synthesis, Computational Studies, and Evaluation of Triazole Acetamide Linked with Phenyl Piperazine Derivatives as Anticancer Agents Against Breast Cancer
Vaishnani, M., Prajapati, A., Bijani, S., Shah, S., Kamal, M., Alsaweed, M., Jain, V. & Iqbal, D., 2025, (Accepted/In press) In: Polycyclic Aromatic Compounds.Research output: Contribution to journal › Article › peer-review
-
Exosomes in infectious diseases: insights into leishmaniasis pathogenesis, immune modulation, and therapeutic potential
Abida, Alhuthali, H. M., Alshehri, J. M., Alkathiri, A., Almaghrabi, R. O. M., Alsaeed, S. S., Albebi, S. A. H., Almethn, R. M., Alfuraydi, B. A., Alharbi, S. B., Kamal, M. & Imran, M., May 2025, In: Naunyn-Schmiedeberg's Archives of Pharmacology. 398, 5, p. 4913-4931 19 p., e4.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Exploring Alectinib and Irinotecan as potential human kallikrein-1 inhibitors: a drug repurposing approach for cancer and dermatological disorders
Jawaid, T., Kamal, M., Al-Keridis, L. A., Adnan, M., Hussain, I., Alshammari, S. O., Alshammari, N., Azum, N. & Mohammad, T., 2025, In: Molecular Simulation. 51, 8, p. 546-558 13 p.Research output: Contribution to journal › Article › peer-review